BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17925564)

  • 1. Chronic myeloid leukemia and gastrointestinal stromal tumor: simultaneous presentation.
    Gollard R; Wierda W; Trent J
    J Clin Oncol; 2007 Oct; 25(29):4682-3. PubMed ID: 17925564
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
    Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
    Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of plasma imatinib concentration for the effective treatment of CML patients.
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Miura T; Kawamura T; Obara S; Tanaka J; Asaka M; Imamura M; Masauzi N
    Leuk Res; 2004 Oct; 28(10):1117-8. PubMed ID: 15289027
    [No Abstract]   [Full Text] [Related]  

  • 4. Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
    Kata D; Mrówka-Kata K; Seweryn M; Pajak J; Najda J; Kyrcz-Krzemień S
    Leuk Res; 2010 Sep; 34(9):e229-31. PubMed ID: 20359744
    [No Abstract]   [Full Text] [Related]  

  • 5. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate.
    Ohnishi K; Sakai F; Kudoh S; Ohno R
    Leukemia; 2006 Jun; 20(6):1162-4. PubMed ID: 16598305
    [No Abstract]   [Full Text] [Related]  

  • 6. A phenomenal response to treatment by an advanced tumour.
    Rahman SH; Roy A; Leahy M; Guillou PJ; Toogood GJ
    Gut; 2004 Nov; 53(11):1582, 1616. PubMed ID: 15479675
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
    D'Arena G; Gemei M; Luciano L; D'Auria F; Deaglio S; Statuto T; Bianchino G; Grieco V; Mansueto G; Guariglia R; Pietrantuono G; Martorelli MC; Villani O; Del Vecchio L; Musto P
    J Clin Oncol; 2012 Nov; 30(32):e327-30. PubMed ID: 23008321
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.
    Arce-Lara C; Shah MH; Jimenez RE; Patel VR; Benson DM; Clinton SK; Monk JP
    Urology; 2007 Jun; 69(6):1209.e5-7. PubMed ID: 17572224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response.
    Press RD; Galderisi C; Yang R; Rempfer C; Willis SG; Mauro MJ; Druker BJ; Deininger MW
    Clin Cancer Res; 2007 Oct; 13(20):6136-43. PubMed ID: 17947479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary thoracic cavity gastrointestinal stromal tumor.
    Cheng JW; Lu SH; Xu ST; Wang H; Hou YY; Zheng RH; Tan YS
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):e29-31. PubMed ID: 20381084
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up study of patients diagnosed with chronic myelogenous leukemia treated with STI 571 in Ecuador.
    Paz-Y-Miño C; Arévalo M; Sánchez ME; Cañizares C; Leone PE
    Arch Med Res; 2007 Apr; 38(3):364-5. PubMed ID: 17350491
    [No Abstract]   [Full Text] [Related]  

  • 12. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
    Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
    Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.
    Orciuolo E; Fazzi R; Galimberti S; Testi C; Azzara' A; Carulli G; Petrini M
    Leuk Res; 2006 Mar; 30(3):349-53. PubMed ID: 16182365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Please, desist RECIST criteria in GIST, at least in me'.
    Sevinc A; Turhal NS
    Onkologie; 2008 Oct; 31(10):556. PubMed ID: 18854657
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic myeloid leukemia:specific characteristics and targeted therapy].
    Nacinović-Duletić A
    Lijec Vjesn; 2007 May; 129 Suppl 3():5-9. PubMed ID: 18972633
    [No Abstract]   [Full Text] [Related]  

  • 16. Unexpected leukocytosis in a preoperative patient.
    McLaren BK; Muldoon R; Veillon DM; Nordberg ML; Weinberger B; Cotelingam JD
    J La State Med Soc; 2002; 154(1):17-9. PubMed ID: 11892878
    [No Abstract]   [Full Text] [Related]  

  • 17. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
    Al-Moundhri MS; Al-Thahli K; Al-Kindy S; Salam J; Rao L
    Saudi Med J; 2006 Oct; 27(10):1585-7. PubMed ID: 17013488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia.
    Bhagavathi S; Borromeo V; Desai H; Crisan D
    Ann Clin Lab Sci; 2008; 38(4):405-9. PubMed ID: 18988937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of cervical stump diagnosed in a woman with chronic myelogenous leukaemia.
    Dogan NU; Gungor T; Sahin I; Karsli F
    J Obstet Gynaecol; 2013 May; 33(4):428-9. PubMed ID: 23654340
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of positron emission and computed tomography scan in early evaluation of treatment response in gastrointestinal stromal tumor.
    Nozaki Y; Yanase M; Masaki N
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):A22. PubMed ID: 19362609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.